Stocks · Health care · Surgical & Medical Instruments & Apparatus

MIMEDX GROUP, INC.

MDXG Clue Score67
United States Fiscal year ends December CIK 0001376339 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kimberly Maersk-Moller
6 Nov 2025
Chief Commercial Officer
Sell
58,300
$7.42
$432.33K
Kimberly Maersk-Moller
17 Mar 2025
Chief Commercial Officer
Sell
1,759
$8.04
$14.14K
Kimberly Maersk-Moller
13 Mar 2025
Chief Commercial Officer
Sell
4,106
$7.89
$32.40K
William Frank Hulse IV
13 Mar 2025
General Counsel and CAO
Sell
20,366
$7.89
$160.69K
William Frank Hulse IV
13 Mar 2025
General Counsel and CAO
Sell
34,230
$7.89
$270.07K
William Frank Hulse IV
10 Mar 2025
General Counsel and CAO
Sell
81,446
$7.80
$635.28K
Kimberly Maersk-Moller
28 Feb 2025
Chief Commercial Officer
Sell
2,111
$8.41
$17.74K
Ricci S Whitlow
13 Feb 2025
Chief Operating Officer
Sell
61,420
$8.28
$508.56K
William Frank Hulse IV
13 Mar 2024
General Counsel and CAO
Sell
20,381
$7.95
$162.03K
Ricci S Whitlow
20 Feb 2024
Chief Operating Officer
Sell
15,271
$8.01
$122.35K
Ricci S Whitlow
16 Feb 2024
Chief Operating Officer
Sell
15,493
$8.07
$125.07K
Ricci S Whitlow
15 Feb 2024
Chief Operating Officer
Sell
15,198
$8.06
$122.50K
Ricci S Whitlow
14 Feb 2024
Chief Operating Officer
Sell
15,845
$8.03
$127.27K
Robert Benjamin Stein
16 May 2023
President, Regenerative Med.
Sell
10,365
$5.95
$61.63K
Robert Benjamin Stein
15 May 2023
President, Regenerative Med.
Sell
3,607
$6.15
$22.17K
Peter M Carlson
10 May 2023
Chief Financial Officer
Sell
5,976
$5.93
$35.41K
William Lawrence Phelan
10 May 2023
Chief Accounting Officer
Sell
1,595
$5.93
$9.45K
Robert Benjamin Stein
10 May 2023
President, Regenerative Med.
Sell
5,869
$5.93
$34.78K
William Frank Hulse IV
10 May 2023
General Counsel and CAO
Sell
5,870
$5.93
$34.79K
Robert Benjamin Stein
4 May 2023
President, Regenerative Med.
Sell
51,756
$5.34
$276.47K
William Lawrence Phelan
2 May 2023
Chief Accounting Officer
Sell
5,200
$3.80
$19.74K
Peter M Carlson
25 Apr 2023
Chief Financial Officer
Sell
6,094
$3.74
$22.82K
William Frank Hulse IV
25 Apr 2023
General Counsel and CAO
Sell
5,988
$3.74
$22.42K
Robert Benjamin Stein
25 Apr 2023
President, Regenerative Med.
Sell
5,987
$3.74
$22.42K
William Lawrence Phelan
25 Apr 2023
Chief Accounting Officer
Sell
1,628
$3.74
$6.10K
Peter M Carlson
11 Apr 2023
Chief Financial Officer
Sell
6,100
$3.31
$20.19K
William Frank Hulse IV
11 Apr 2023
General Counsel and CAO
Sell
5,995
$3.31
$19.84K
Robert Benjamin Stein
11 Apr 2023
President, Regenerative Med.
Sell
5,996
$3.31
$19.85K
William Lawrence Phelan
11 Apr 2023
Chief Accounting Officer
Sell
1,632
$3.31
$5.40K
William Frank Hulse IV
7 Mar 2023
General Counsel and CAO
Sell
11,308
$4.24
$48.00K
Peter M Carlson
7 Mar 2023
Chief Financial Officer
Sell
12,056
$4.24
$51.17K
William Lawrence Phelan
7 Mar 2023
Chief Accounting Officer
Sell
3,396
$4.24
$14.41K
Robert Benjamin Stein
7 Mar 2023
President, Regenerative Med.
Sell
12,355
$4.24
$52.44K
William Frank Hulse IV
23 Feb 2023
General Counsel and CAO
Sell
15,555
$4.53
$70.48K
Peter M Carlson
23 Feb 2023
Chief Financial Officer
Sell
19,000
$4.50
$85.42K
Peter M Carlson
22 Dec 2022
Chief Financial Officer
Sell
4,992
$2.82
$14.05K
Robert Benjamin Stein
13 Sep 2022
President, Regenerative Med.
Sell
8,329
$3.46
$28.79K
Robert Benjamin Stein
12 Sep 2022
President, Regenerative Med.
Sell
19,000
$3.44
$65.28K
Robert Benjamin Stein
12 Aug 2022
President, Regenerative Med.
Sell
8,503
$4.04
$34.34K
Rohit Kashyap
9 Aug 2022
President, WC & Surgical
Sell
12,343
$4.21
$51.94K
Robert Benjamin Stein
4 Aug 2022
President, Regenerative Med.
Sell
19,500
$3.62
$70.59K
Robert Benjamin Stein
28 Jun 2022
President, Regenerative Med.
Sell
14,600
$3.47
$50.66K
Timothy R Wright
9 Jun 2022
Chief Executive Officer
Sell
112,000
$3.75
$420.00K
Mark Graves
9 May 2022
SVP & Chief Compliance Officer
Sell
3,891
$3.50
$13.62K
William Lawrence Phelan
6 May 2022
Chief Accounting Officer
Sell
5,750
$3.81
$21.91K
Scott M Turner
2 May 2022
SVP, Operations & Procurement
Sell
5,260
$4.00
$21.05K
William Lawrence Phelan
8 Mar 2022
Chief Accounting Officer
Sell
3,268
$4.86
$15.88K
Robert Benjamin Stein
8 Mar 2022
EVP, Research and Development
Sell
11,672
$4.86
$56.71K
William Frank Hulse IV
8 Mar 2022
General Counsel
Sell
9,990
$4.86
$48.54K
Peter M Carlson
8 Mar 2022
Chief Financial Officer
Sell
10,743
$4.86
$52.20K
Mark Graves
8 Mar 2022
SVP & Chief Compliance Officer
Sell
3,234
$4.86
$15.71K
Rohit Kashyap
8 Mar 2022
EVP & Chief Commercial Officer
Sell
8,770
$4.86
$42.61K
Scott M Turner
8 Mar 2022
SVP, Operations & Procurement
Sell
4,155
$4.86
$20.19K
Timothy R Wright
8 Mar 2022
Chief Executive Officer
Sell
45,611
$4.86
$221.62K
Peter M Carlson
25 Feb 2022
Chief Financial Officer
Sell
17,400
$4.83
$84.08K
Mark Graves
24 Feb 2022
SVP & Chief Compliance Officer
Sell
4,525
$4.32
$19.54K
William Frank Hulse IV
23 Feb 2022
General Counsel
Sell
13,500
$4.41
$59.54K
Scott M Turner
23 Feb 2022
SVP, Operations & Procurement
Sell
5,738
$4.50
$25.82K
Timothy R Wright
23 Feb 2022
Chief Executive Officer
Sell
61,000
$4.31
$263.07K
Robert Benjamin Stein
16 Aug 2021
EVP, Research and Development
Sell
9,362
$11.85
$110.97K
Timothy R Wright
8 Jun 2021
Chief Executive Officer
Sell
101,957
$0.00
$0.00
Okumus Fund Management Ltd.
23 Jan 2019
10% owner
Sell indirect
0
$0.00
$0.00
Okumus Fund Management Ltd.
23 Jan 2019
10% owner
Sell indirect
0
$0.00
$0.00
Okumus Fund Management Ltd.
23 Jan 2019
10% owner
Sell
1,531,700
$2.78
$4.27M
Okumus Fund Management Ltd.
22 Jan 2019
10% owner
Sell indirect
0
$0.00
$0.00
Okumus Fund Management Ltd.
22 Jan 2019
10% owner
Sell indirect
0
$0.00
$0.00
Okumus Fund Management Ltd.
22 Jan 2019
10% owner
Sell
460,000
$2.88
$1.32M
William Charles Taylor
25 May 2017
President and COO
Sell
26,571
$13.74
$364.96K
William Charles Taylor
27 Apr 2017
President and COO
Sell
26,000
$11.40
$296.49K
Charles E Koob
13 Mar 2017
Director
Sell
50,486
$8.50
$429.14K
William Charles Taylor
6 Mar 2017
President and COO
Sell
26,000
$8.18
$212.79K

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 71
Transactions with no price 0
Shares from compensation/vesting 42,227,945
Sales filed before the plan box existed 42
History held since 12 Feb 2008